Does RIVAROXABAN Cause Product packaging quantity issue? 174 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Product packaging quantity issue have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.1% of all adverse event reports for RIVAROXABAN.
174
Reports of Product packaging quantity issue with RIVAROXABAN
0.1%
of all RIVAROXABAN reports
2
Deaths
14
Hospitalizations
How Dangerous Is Product packaging quantity issue From RIVAROXABAN?
Of the 174 reports, 2 (1.1%) resulted in death, 14 (8.0%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 174 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
EXENATIDE (154)
LIFITEGRAST (153)
Which RIVAROXABAN Alternatives Have Lower Product packaging quantity issue Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM